Overview

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

This study will assess the safety and tolerability of pancrelipase delayed release capsules in subjects up to 6 years of age with Pancreatic Exocrine Insufficiency (PEI) due to Cystic Fibrosis.

Phase:

Phase 3

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Pancreatin
Pancrelipase